Gerresheimer (GXI) Given a €55.00 Price Target at Hauck & Aufhaeuser
Other equities research analysts have also issued reports about the company. JPMorgan Chase & Co. set a €99.40 ($122.72) target price on Gerresheimer and gave the company a buy rating in a research report on Wednesday, October 11th. Berenberg Bank set a €75.00 ($92.59) target price on Gerresheimer and gave the company a buy rating in a research report on Wednesday, October 11th. Credit Suisse Group set a €80.00 ($98.77) target price on Gerresheimer and gave the company a buy rating in a research report on Tuesday, October 10th. Commerzbank set a €77.00 ($95.06) target price on Gerresheimer and gave the company a buy rating in a research report on Monday, October 23rd. Finally, set a €65.00 ($80.25) target price on Gerresheimer and gave the company a neutral rating in a research report on Tuesday, October 17th. Two analysts have rated the stock with a sell rating, five have given a hold rating and five have given a buy rating to the company’s stock. Gerresheimer currently has a consensus rating of Hold and a consensus target price of €71.61 ($88.41).
Shares of Gerresheimer (ETR GXI) opened at €66.20 ($81.73) on Tuesday. The stock has a market capitalization of $2,080.00 and a P/E ratio of 46.95. Gerresheimer has a one year low of €59.97 ($74.04) and a one year high of €78.25 ($96.60).
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.